%D9%81%D9%8A%D8%B1%D8%A7%D8%A8%D8%A7%D9%85%D9%8A%D9%84%D9%88%D8%B1%D8%A7%D9%BE%D8%A7%D9%85%DB%8C%D9%84Category:VerapamilFerapamilVerapamilVerapamilVerapamilVerapamilo%D9%88%D8%B1%D8%A7%D9%BE%D8%A7%D9%85%DB%8C%D9%84VerapamiiliV%C3%A9rapamil%D7%95%D7%A8%D7%90%D7%A4%D7%90%D7%9E%D7%99%D7%9CVerapamil%D5%8E%D5%A5%D6%80%D5%A1%D5%BA%D5%A1%D5%B4%D5%AB%D5%ACVerapamilVerapamil%E3%83%99%E3%83%A9%E3%83%91%E3%83%9F%E3%83%ABVerapamil%E0%AC%AD%E0%AD%87%E0%AC%B0%E0%AC%BE%E0%AC%AA%E0%AC%BE%E0%AC%AE%E0%AC%BF%E0%AC%B2WerapamilVerapamil%D0%92%D0%B5%D1%80%D0%B0%D0%BF%D0%B0%D0%BC%D0%B8%D0%BBVerapamilVerapamilVerapamilVerapamil%D0%92%D0%B5%D1%80%D0%B0%D0%BF%D0%B0%D0%BC%D1%96%D0%BBVerapamilQ410291%E7%BB%B4%E6%8B%89%E5%B8%95%E7%B1%B3
about
Calcium voltage-gated channel subunit alpha1 CSodium leak channel, non-selectiveCalcium voltage-gated channel subunit alpha1 DTwo pore segment channel 2Two pore segment channel 1Potassium voltage-gated channel subfamily A member 10Potassium voltage-gated channel subfamily A member 7Calcium voltage-gated channel subunit alpha1 SSolute carrier family 29 member 4Potassium inwardly-rectifying channel, subfamily J, member 6Voltage-dependent L-type calcium channel subunit alpha-1FCytochrome P450 family 3 subfamily A member 4
P129
Sapropterin Expanded Access ProgramA Phase 2 Study of the Effects of 6R-BH4 in Subjects With Sickle Cell DiseaseTherapy With Verapamil or Carvedilol in Chronic Heart FailureDrug Discrimination in Methadone-Maintained Humans Study 3Study Investigating the Pharmacokinetic Interaction Between INX-08189 and Verapamil HCL ER in Healthy VolunteersComparative Bioavailability Study of Synerx and Verelan PM 300 mg Verapamil HCl ER Capsules Under Fed ConditionsRandomized Controlled Trial to Assess the Effects of Sapropterin on Hepatic and Systemic Hemodynamics in Patients With Liver Cirrhosis and Portal HypertensionThe Intra-arterial Vasospasm TrialKuvan®'s Effect on the Cognition of Children With PhenylketonuriaStudy to Evaluate the Response to and Safety of an 8-Day Course of Phenoptin™ Treatment in Subjects With PhenylketonuriaStudy to Evaluate the Safety and Efficacy of Phenoptin™ in Subjects With Phenylketonuria Who Have Elevated Phenylalanine LevelsStudy Evaluating The Potential Interaction Between Verapamil Immediate Release And SAM-531 When Co-AdministeredDrug Discrimination in Methadone-Maintained Humans Study 2CiPA Phase 1 ECG Biomarker Validation StudySuppression Of Atrial Fibrillation With Ranolazine After Cardiac SurgeryComparison of Medical Therapies in Marfan Syndrome.A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxinThis Study Tests the Effect of Certain Medicines on the Transport of Other Medicines in the Body of Healthy MenBrentuximab Vedotin, Cyclosporine, and Verapamil in Treating Patients With Relapsed or Refractory Hodgkin LymphomaDrug Interaction Study With RV521 in Healthy Volunteer SubjectsIs Verapamil In TransRadial Interventions OmittabLe?Kuvan® in Phenylketonuria Patients Less Than 4 Years OldEvaluation of Behavior, Executive Function, Neurotransmitter Function and Genomic Expression Kuvan NonrespondersDrug-Disease Interaction in Crohn's DiseaseSafety and Therapeutic Effects of Sapropterin Dihydrochloride on Neuropsychiatric Symptoms in Phenylketonuria (PKU) PatientsTetrahydrobiopterin Treatment in Children With Idiopathic Cognitive Developmental DisordersImpact of KUVAN® on Gastric Relaxation in Women With Diabetic Gastroparesis.Cystic Fibrosis and Endothelial Function: At Rest and During ExerciseThe Effects of Sapropterin Dihydrochloride Supplementation on in Vivo Redox Status in Patients With Classical PKUSafety, Tolerability, and Efficacy of IA Verapamil in the Treatment of Joint Pain in Subjects With Osteoarthritis of the KneeOral Verapamil in Acute Paroxysmal Supra Ventricular Tachycardia(PSVT) Recurrence ControlVerapamil as Therapy for Children and Young Adults With Dravet SyndromeRate Control in Atrial FibrillationEffects of Different Vasodilators on Coronary No-reflow During primAry percuTaneous Coronary intErvention in Patients With Acute Myocardial InfarctionAn Interaction Study of Ketoconazole/Verapamil Versus AZD1305Combination of Hydroxyurea and Verapamil for Refractory MeningiomasNutritional and Neurotransmitter Changes in PKU Subjects on BH4Blood Pressure and Weight Trajectory on a Dual Antihypertensive Combination Plus Sibutramine Versus Placebo in Obese HypertensivesBioequivalence Study Of VerapamilSapropterin on Cognitive Abilities in Young Adults With Phenylketonuria
P4844
Fractional clearance for verapamil N-demethylation in the isolated rat liver preparation.Comparing the Efficacy of Intralesional Triamcinolone Acetonide With Verapamil in Treatment of Keloids: A Randomized Controlled TrialComparison of Fractional CO Laser, Verapamil, and Triamcinolone for the Treatment of KeloidEffect of Local Administration of Verapamil Combined with Chitosan Based Hybrid Nanofiber Conduit on Transected Sciatic Nerve in RatEffects of Verapamil and Diltiazem on the Pharmacokinetics and Pharmacodynamics of Rivaroxaban
P921
P924
Q1499998-B619BBB9-A8C7-41B3-99A6-08F82FEEC9C9Q21096262-A55DC5CA-AB4F-4E38-A5E0-66A848AB46D0Q21102146-6BC6C40D-38D1-49F1-9937-FCE2D4687DBEQ21103323-CE3CBB52-CD01-49A5-AB54-EF39B0EF71D5Q21103337-4D9CF7F2-D490-4F13-97A6-E824C9341733Q21107843-F65AD322-6964-497B-8E67-2B83A4356B2FQ21107890-C34119CD-5F2F-4564-A13C-A576D0FB687BQ21111803-E322738C-8E7A-47E4-914C-273C2EF6618DQ21134814-A09EA8BD-84F1-4579-A5AD-9B560692E980Q21497878-198CD0B2-8CEE-4EF5-B12F-E9F0F6FA5979Q21984383-5BF74B1B-DBF5-46EE-A6B3-85FE07E4E20BQ424440-F9C46023-91AD-4932-9EC8-DA4CF2BA8C47
P129
description
Arzneistoff, organische Nitrilverbindung
@de
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Verapamiili
@fi
Verapamil
@da
Verapamil
@de
Verapamil
@hu
Verapamil
@id
Verapamil
@it
Verapamil
@nl
Verapamil
@sh
Verapamil
@sl
Verapamil
@sv
type
label
Verapamiili
@fi
Verapamil
@da
Verapamil
@de
Verapamil
@hu
Verapamil
@id
Verapamil
@it
Verapamil
@nl
Verapamil
@sh
Verapamil
@sl
Verapamil
@sv
altLabel
36622-29-4
@fr
38321-02-7
@fr
52-53-9
@fr
Ansyr®
@cy
Ansyr®
@en
C27H38N2O4
@fr
C27H38N2O4
@it
CP-165331 / CP-16533-1
@cy
CP-165331 / CP-16533-1
@en
Iproveratril
@en
prefLabel
Verapamiili
@fi
Verapamil
@da
Verapamil
@de
Verapamil
@hu
Verapamil
@id
Verapamil
@it
Verapamil
@nl
Verapamil
@sh
Verapamil
@sl
Verapamil
@sv